Why Korea Leads the World in Regenerative Medicine

Why Korea Leads the World in Regenerative Medicine

As of 2026, Korea ranks 3rd globally in regenerative medicine publications and 1st in approved stem cell therapeutics. Behind these achievements are aggressive government R&D investment, world-class medical infrastructure, and a rapid clinical application system.

Government-Led Bio R&D Investment

The Korean government has invested over ₩500 billion annually in regenerative medicine since 2020, expanding to ₩800 billion in 2026 — the second largest in Asia after Japan.

World's First Approved Stem Cell Therapeutics

Korea was the first country to officially approve stem cell therapeutics. To date, five stem cell therapies have been approved and are actively used in clinical practice.

The Fusion of K-Beauty and Regenerative Medicine

Korea's unique strength lies in innovative treatments that blur the line between cosmetics and regenerative medicine — stem cell growth factor skincare, exosome-based anti-aging, and combined regenerative laser-stem cell therapies.

Why Get Treated in Korea

1) World-leading technology 2) 1/3 to 1/5 the cost of the US and Japan 3) State-of-the-art facilities and equipment 4) Multilingual medical coordinators. Experience the future of regenerative medicine in Korea.